Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 26, 2015 7:12 PM ET


Company Overview of Theron Pharmaceuticals, Inc.

Company Overview

Theron Pharmaceuticals, Inc., a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its TRN-157 is a preclinical development program that focuses on the treatment of chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.

365 San Aleso Avenue

Sunnyvale, CA 94085

United States

Founded in 2008





Key Executives for Theron Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer and Director
Co-Founder and Director
Scientific Advisor
Inhalation Formulation Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Keraplast Technologies Ltd. United States
Dilyx Biotechnologies, LLC United States
TocopheRx United States
CytImmune Sciences, Inc. United States
Xylos Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Theron Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at